YungShin Global Holding Corp - Asset Resilience Ratio
YungShin Global Holding Corp (3705) has an Asset Resilience Ratio of 9.74% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 3705 working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2000–2025)
This chart shows how YungShin Global Holding Corp's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see balance sheet size of YungShin Global Holding Corp.
Liquid Assets Composition Over Time
This chart breaks down YungShin Global Holding Corp's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore YungShin Global Holding Corp long-term investment allocation to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 0% |
| Short-term Investments | NT$1.28 Billion | 9.74% |
| Total Liquid Assets | NT$1.28 Billion | 9.74% |
Asset Resilience Insights
- Limited Liquidity: YungShin Global Holding Corp maintains only 9.74% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
YungShin Global Holding Corp Industry Peers by Asset Resilience Ratio
Compare YungShin Global Holding Corp's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
ST:SOBI |
Drug Manufacturers - Specialty & Generic | 1.54% |
|
Yunnan Baiyao Group Co Ltd
SHE:000538 |
Drug Manufacturers - Specialty & Generic | 8.38% |
|
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317 |
Drug Manufacturers - Specialty & Generic | 6.62% |
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK |
Drug Manufacturers - Specialty & Generic | 4.94% |
|
Harbin Gloria Pharmaceuticals
SHE:002437 |
Drug Manufacturers - Specialty & Generic | 9.04% |
|
Jiuzhitang Co Ltd
SHE:000989 |
Drug Manufacturers - Specialty & Generic | 7.86% |
|
Renhe Pharmacy Co Ltd
SHE:000650 |
Drug Manufacturers - Specialty & Generic | 37.54% |
|
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557 |
Drug Manufacturers - Specialty & Generic | 0.29% |
Annual Asset Resilience Ratio for YungShin Global Holding Corp (2000–2025)
The table below shows the annual Asset Resilience Ratio data for YungShin Global Holding Corp.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 9.91% | NT$1.25 Billion ≈ $39.37 Million |
NT$12.61 Billion ≈ $397.36 Million |
+6.75pp |
| 2024-12-31 | 3.16% | NT$435.39 Million ≈ $13.72 Million |
NT$13.80 Billion ≈ $434.72 Million |
+0.37pp |
| 2023-12-31 | 2.79% | NT$321.13 Million ≈ $10.12 Million |
NT$11.51 Billion ≈ $362.70 Million |
+2.24pp |
| 2022-12-31 | 0.55% | NT$65.48 Million ≈ $2.06 Million |
NT$11.85 Billion ≈ $373.43 Million |
+0.01pp |
| 2021-12-31 | 0.55% | NT$65.48 Million ≈ $2.06 Million |
NT$12.01 Billion ≈ $378.36 Million |
-0.96pp |
| 2020-12-31 | 1.51% | NT$190.36 Million ≈ $6.00 Million |
NT$12.61 Billion ≈ $397.34 Million |
+1.31pp |
| 2019-12-31 | 0.20% | NT$24.75 Million ≈ $779.92K |
NT$12.36 Billion ≈ $389.39 Million |
-0.03pp |
| 2018-12-31 | 0.23% | NT$26.54 Million ≈ $836.22K |
NT$11.77 Billion ≈ $370.68 Million |
+0.53pp |
| 2017-12-31 | -0.30% | NT$-33.02 Million ≈ $-1.04 Million |
NT$11.02 Billion ≈ $347.14 Million |
+0.15pp |
| 2016-12-31 | -0.45% | NT$-45.43 Million ≈ $-1.43 Million |
NT$10.19 Billion ≈ $321.06 Million |
+0.53pp |
| 2015-12-31 | -0.97% | NT$-90.28 Million ≈ $-2.84 Million |
NT$9.26 Billion ≈ $291.90 Million |
-0.09pp |
| 2014-12-31 | -0.88% | NT$-76.55 Million ≈ $-2.41 Million |
NT$8.69 Billion ≈ $273.83 Million |
-1.24pp |
| 2013-12-31 | 0.36% | NT$29.62 Million ≈ $933.26K |
NT$8.23 Billion ≈ $259.25 Million |
-0.15pp |
| 2012-12-31 | 0.51% | NT$37.86 Million ≈ $1.19 Million |
NT$7.40 Billion ≈ $233.05 Million |
+0.20pp |
| 2011-12-31 | 0.31% | NT$22.73 Million ≈ $716.15K |
NT$7.32 Billion ≈ $230.52 Million |
-1.95pp |
| 2006-12-31 | 2.26% | NT$131.55 Million ≈ $4.14 Million |
NT$5.82 Billion ≈ $183.52 Million |
-4.52pp |
| 2005-12-31 | 6.78% | NT$394.55 Million ≈ $12.43 Million |
NT$5.82 Billion ≈ $183.41 Million |
+1.08pp |
| 2004-12-31 | 5.69% | NT$394.55 Million ≈ $12.43 Million |
NT$6.93 Billion ≈ $218.35 Million |
-2.96pp |
| 2003-12-31 | 8.66% | NT$565.01 Million ≈ $17.80 Million |
NT$6.53 Billion ≈ $205.65 Million |
+4.07pp |
| 2002-12-31 | 4.58% | NT$291.57 Million ≈ $9.19 Million |
NT$6.36 Billion ≈ $200.37 Million |
-0.01pp |
| 2001-12-31 | 4.60% | NT$288.00 Million ≈ $9.07 Million |
NT$6.26 Billion ≈ $197.35 Million |
+3.25pp |
| 2000-12-31 | 1.35% | NT$75.00 Million ≈ $2.36 Million |
NT$5.56 Billion ≈ $175.19 Million |
-- |
About YungShin Global Holding Corp
YungShin Global Holding Corporation, through its subsidiaries, engages in investing, manufacturing, and sale of medicines, veterinary drugs, agricultural chemicals, industrial medicines, and cosmetics. It is also involved in the sale of medicine; trade, investment, and other related businesses; import and export trading; and food manufacturing. The company operates in Taiwan, the United States, M… Read more